Core Laboratories (CLB) Change in Accured Expenses (2022 - 2025)
Core Laboratories' Change in Accured Expenses history spans 4 years, with the latest figure at -$4.5 million for Q4 2025.
- For Q4 2025, Change in Accured Expenses fell 189.16% year-over-year to -$4.5 million; the TTM value through Dec 2025 reached -$2.7 million, down 8115.15%, while the annual FY2025 figure was -$2.7 million, 8115.15% down from the prior year.
- Change in Accured Expenses reached -$4.5 million in Q4 2025 per CLB's latest filing, down from $2.7 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $11.1 million in Q4 2022 to a low of -$5.1 million in Q3 2023.
- Average Change in Accured Expenses over 4 years is $297571.4, with a median of $324000.0 recorded in 2023.
- The largest YoY upside for Change in Accured Expenses was 891.03% in 2025 against a maximum downside of 1545.19% in 2025.
- A 4-year view of Change in Accured Expenses shows it stood at $11.1 million in 2022, then crashed by 72.75% to $3.0 million in 2023, then tumbled by 151.42% to -$1.6 million in 2024, then plummeted by 189.16% to -$4.5 million in 2025.
- Per Business Quant, the three most recent readings for CLB's Change in Accured Expenses are -$4.5 million (Q4 2025), $2.7 million (Q3 2025), and -$1.5 million (Q2 2025).